CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Valiant Mona LSA Thoracic Stent Graft Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02365467
NCT02365467N/ACompleted

Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending Thoracic Aortic Aneurysms and Chronic Dissections

Medtronic Cardiovascular·interventional·Posted Feb 19, 2015·Updated Aug 17, 2025

In Brief

A clinical study evaluating Valiant Mona LSA Thoracic Stent Graft System for Aortic Aneurysm, Thoracic, Chronic Type B Dissection. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The purpose of the Feasibility study is to characterize the safety of the Valiant Mona LSA Thoracic Stent Graft System, including an assessment of the safety and effectiveness of the device acutely and at the 30 day visit in the identified subject population. This study will also evaluate the current instructions for use and may direct changes to the delivery and deployment steps. The purpose of the expansion to the Feasibility Study is to characterize the Valiant Mona LSA Thoracic Stent Graft System, in particular to assess the safety and effectiveness of the device acutely and at the 30 day visit, in subjects enrolled with chronic, Type B dissections.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 19, 2015
Enrollment StartApr 16, 2015
Primary CompletionSep 20, 2019
Study CompletionDec 5, 2024
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 11.4 years ago

Interventions

Valiant Mona LSA Thoracic Stent Graft Systemdevice